Summary: In December 2021, John Chiminski was featured on the expert panel of STAT’s "A Look Ahead at Biotech in 2022" event, which focused on the ongoing battle against the SARS-CoV-2 virus and explored what might be in store for the biotech industry in the years to come.

Summary: On December 13, 2021, EuropaBio hosted the final event of its 25th Anniversary programme with a focus on the story of mRNA.

Summary: Supply chains have come under intense pressure, and companies have had to adapt to this “new normal” to avoid delays. During this Q&A, Catalent discusses....

Summary: Join us as we honor a group of 20 extraordinary women who are making lasting impacts in the drug development field.

Summary: Join Claudia Berdugo, Ph.D., Director of Process Development at Catalent Biologics, for a podcast where she discusses N-1 perfusion and how Catalent Biologics works toward process improvements....

Summary: Experts discuss formulation development and purification strategies to increase throughput, reduce operating costs and decrease...

Summary: During this Q&A, we discuss the challenges of mRNA development and manufacturing, potential solutions and where the industry may go next with mRNA therapies.

Summary: During this talk, hear the latest data leveraging GPEx Lightning to generate highly stable, highly productive cell pools and discuss how the GPEx...

Summary: This webinar offers tips for incorporating elements of the successful COVID-19 vaccine rollout into future vaccine programs.

Summary: Catalent Biologics’ drug substance biomanufacturing services provide flexibility and scale to support your growth from clinical to commercial, with options to utilize single-use or stainless-steel bioreactors in a rigorous CGMP environment.